Standout Papers

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice 2021 2026 2022 2024194
  1. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice (2021)
    Eriya Kenjo, Hiroyuki Hozumi et al. Nature Communications

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
2024 Standout
1 intermediate paper

Works of Maya Kimura being referenced

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
2021 Standout

Author Peers

Author Last Decade Papers Cites
Maya Kimura 225 12 23 60 50 9 334
Devin B. Mair 142 7 22 24 83 14 366
Guilhem Clary 138 1 23 41 17 11 337
Justin A. Peruzzi 243 2 12 14 62 15 305
Allen L. Bell 126 3 44 36 18 8 329
Poulomi Ray 133 18 22 90 10 302
Y. Hirayama 162 2 27 35 16 20 343
Hanna J. Wagner 222 10 40 63 91 20 335
Penny L. Moore 123 6 22 7 42 6 263
Megan Robinson 177 15 29 56 10 296
Ptissam Bergam 244 5 57 31 10 365

All Works

Loading papers...

Rankless by CCL
2026